Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 201 to 250 of 3228 in total 
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor 4 isoform b; rna-binding protein. [source:refseq;acc:nm\_021164]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.382\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13601\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRPC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
short transient receptor potential channel 4 (trpc4) (trp-related protein 4) (htrp-4) (htrp4). [source:swissprot;acc:q9ubn4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.478\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.784\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBC1D10A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ebp50-pdz interactor of 64 kda (epi64 protein). [source:swissprot;acc:q9bxi6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
201.515\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
228.752\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13516\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRPC5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
short transient receptor potential channel 5 (trpc5) (htrp-5) (htrp5). [source:swissprot;acc:q9ul62]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LUC7L2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
luc7-like 2; cgi-74 protein; cgi-59 protein. [source:refseq;acc:nm\_016019]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.968\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13501\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LUC7L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
luc7-like; sarcoplasmic reticulum protein luc7b1. [source:refseq;acc:nm\_018032]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.085\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.006\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13472\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSEN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
presenilin 2 (ps-2) (stm-2) (e5-1) (ad3lp) (ad5). [source:swissprot;acc:p49810]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
285.684\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
252.234\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13261\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SKP1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FBXW7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CUL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSEN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
presenilin 1 (ps-1) (s182 protein). [source:swissprot;acc:p49768]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CUL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PLDN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pallidin; pallid (mouse) homolog, pallidin. [source:refseq;acc:nm\_012388]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.693\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
186.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.127\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LASS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lag1 longevity assurance homolog 2 isoform 1; l3 pigment; tumor metastasis-suppressor. [source:refseq;acc:nm\_022075]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
170.192\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
112\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
126\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.125\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH7B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYH13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC15A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
oligopeptide transporter, kidney isoform (peptide transporter 2) (kidney h+/peptide cotransporter) (solute carrier family 15, member 2). [source:swissprot;acc:q16348]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
165.623\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12285\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.769\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12243\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COMP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cartilage oligomeric matrix protein precursor (comp). [source:swissprot;acc:p49747]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.991\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
269.238\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THBS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thrombospondin 3 precursor. [source:swissprot;acc:p49746]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
269.234\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12186\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH2D3C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh2 domain containing 3c; novel sh2-containing protein 3; sh2 domain-containing 3c; likely ortholog of mouse cas/hef1-associated signal transducer. [source:refseq;acc:nm\_005489]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12036\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BCAR3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
breast cancer antiestrogen resistance 3. [source:refseq;acc:nm\_003567]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.401\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSRP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cysteine-rich protein 1 (crp1) (crp). [source:swissprot;acc:p21291]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.915\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11934\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SHCBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
likely ortholog of mouse shc sh2-domain binding protein 1. [source:refseq;acc:nm\_024745]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
239.336\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.881\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11927\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSRP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
smooth muscle cell lim protein (cysteine-rich protein 2) (crp2) (lim-only protein 5). [source:swissprot;acc:q16527]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
267.879\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSRP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim domain protein, cardiac (muscle lim protein) (cysteine-rich protein 3) (crp3). [source:swissprot;acc:p50461]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
267.842\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11918\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHRAC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
287.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
256.835\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11905\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phenylalanine-4-hydroxylase (ec 1.14.16.1) (pah) (phe-4- monooxygenase). [source:swissprot;acc:p00439]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
227.357\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
254.15\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11785\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DUS1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pp3111 protein. [source:refseq;acc:nm\_022156]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STX18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
syntaxin 18. [source:swissprot;acc:q9p2w9]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rd protein. [source:swissprot;acc:p18615]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AIG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
androgen-induced 1; cgi-103 protein; androgen induced protein. [source:refseq;acc:nm\_016108]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP5F1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase b chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p24539]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNAJC12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
j domain containing protein 1. [source:swissprot;acc:q9ukb3]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNX13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.109\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.333\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11751\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF4G3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma, 3. [source:refseq;acc:nm\_003760]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
237.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.363\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11748\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
247\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
237.302\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.41\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11719\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
248\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYNCRIP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRNPR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Hugo is the HGNC identifier if it exists
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/